Phosphodiesterase-4 inhibitor - PDFSEARCH.IO - Document Search Engine

Phosphodiesterase-4 inhibitor
Results: 23

#	Item
1	PDF Document Add to Reading List Source URL: www.goldcopd.org Language: English Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Obstructive lung disease Acute exacerbation of chronic obstructive pulmonary disease Bronchial hyperresponsiveness Respiratory disease Asthma Phosphodiesterase-4 inhibitor Pulmonology Medicine Respiratory therapy
2	ADCIRCA® (tadalafil) NAME OF THE MEDICINE ADCIRCA® (tadalafil). Chemically, tadalafil is pyrazino[1’, 2’:1, 6]pyrido[3, 4-b]indole-1, 4-dione, 6-(1, 3benzodioxol-5-yl)-2, 3, 6, 7, 12, 12a-hexahydro-2-methyl-, (6R, Add to Reading List Source URL: gp2u.com.au Language: English - Date: 2013-08-31 02:43:59 Lactams PDE5 inhibitors Tadalafil Human sexuality CGMP-specific phosphodiesterase type 5 Pulmonary hypertension Phosphodiesterase inhibitor Erectile dysfunction High altitude pulmonary edema Chemistry Eli Lilly and Company Organic chemistry
3	Briefing Book - April 2010 Add to Reading List Source URL: www.fda.gov Language: English Chronic lower respiratory diseases Chronic obstructive pulmonary disease Smoking Phosphodiesterase-4 inhibitor Acute exacerbation of chronic obstructive pulmonary disease Roflumilast Spirometry Tiotropium bromide Pulmonology Respiratory therapy Medicine
4	Docket No. OON[removed]Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane rm[removed]Rockville Add to Reading List Source URL: www.fda.gov Language: English - Date: 2000-10-23 04:30:37 Pathology MRCVS Newsholme Veterinary physician University of the Philippines Los Baños College of Veterinary Medicine Phosphodiesterase-4 inhibitor Medicine Veterinary pathology Veterinary medicine
5	Effects of cAMP-dependent protein kinase activator and inhibitor on in vivo rolipram binding to phosphodiesterase 4 in conscious rats Add to Reading List Source URL: intramural.nimh.nih.gov Language: English - Date: 2010-01-04 11:40:27 Neuroimaging Molecular biology Signal transduction Rolipram Phosphodiesterase-4 inhibitor Neurotransmitters Positron emission tomography Protein kinase A Phosphodiesterase 4 Biology Medicine Biochemistry
6	Phosphodiesterase 4D is required for ␤2 adrenoceptor subtype-specific signaling in cardiac myocytes Yang Xiang†, Fabio Naro†‡§, Maria Zoudilova‡, S.-L. Catherine Jin‡, Marco Conti‡¶, and Brian Kobilka¶ Add to Reading List Source URL: med.stanford.edu Language: English - Date: 2009-12-04 19:10:48 Phosphodiesterase inhibitor Amrinone CGMP-specific phosphodiesterase type 5 Phosphodiesterase Phospholamban Rolipram Heart failure Myocyte CAMP-dependent pathway Biology Phosphodiesterase-4 inhibitor Pyridines
7	PRIOR AUTHORIZATION POLICY Otezla® (apremilast tablets – Celgene Corporation) To Initiate a Coverage Review, Call[removed]OVERVIEW Otezla, a phosphodiesterase 4 (PDE4) inhibitor, is indicated for treatment of a Add to Reading List Source URL: statehealthplan.state.nc.us Language: English - Date: 2014-05-29 15:15:36 Pharmacology Adalimumab Psoriasis Leflunomide Ustekinumab Psoriatic arthritis Etanercept Golimumab Infliximab Immunosuppressants Medicine Immunology
8	CHAPTER 1 AL cAMP-Specific Phosphodiesterases: Modulation, Inhibition, and Activation Add to Reading List Source URL: media.wiley.com Language: English - Date: 2013-08-27 10:18:46 Molecular biology Protein kinases Cell biology Phosphodiesterase-4 inhibitor Phosphodiesterase Cyclic nucleotide phosphodiesterase Protein kinase A PDE3 Glycogen phosphorylase Biology Signal transduction Cell signaling
9	Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients With Psoriatic Arthritis and Current Skin Involvement: Results of a Phase 3, Randomized, Controlled Trial (PALACE 3) Add to Reading List Source URL: aplarcongress.org Language: English - Date: 2014-04-23 02:58:19 Immunology Psoriasis Arthritis Autoimmune diseases Organofluorides Psoriatic arthritis Leflunomide Placebo Disease-modifying antirheumatic drug Medicine Immunosuppressants Health
10	23 June 2014 Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma reports Phase IIa headline results for VRP700 Verona Pharma plc (AIM: VRP), the drug development company focused on “first-in-class” med Add to Reading List Source URL: www.veronapharma.com Language: English - Date: 2014-06-23 02:26:16 Chronic lower respiratory diseases Pulmonary function testing Chronic obstructive pulmonary disease Smoking Phosphodiesterase-4 inhibitor Bronchodilator Cough Asthma Respiratory disease Pulmonology Medicine Respiratory therapy